-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Kestra Medical Techs, Raises Price Target to $32

Benzinga·07/15/2026 11:08:14
Listen to the news
BTIG analyst Marie Thibault maintains Kestra Medical Techs (NASDAQ:KMTS) with a Buy and raises the price target from $30 to $32.